4‐Octyl Itaconate Attenuates Age‐Induced Parotid Gland Dysfunction Through the Suppression of Fibrosis and Lipid Deposition by AMPKα/PPARα and the Inhibition of Oxidative Stress via the AMPKα/Nrf2 Signaling Pathway
Treatment with 4‐OI improved the aging of the parotid gland by increasing gland FAO, decreasing gland fibrosis, and preventing oxidative reactions, and upregulating the AMPKα/Nrf2 and AMPKα/PPARα signaling pathways.
Abstract
Parotid gland aging is a key factor for reduced salivary production in older individuals. The role of 4‐Octyl itaconate (4‐OI) in age‐related parotid gland dysfunction remains unclear. Thirteen‐month‐old male mice were administered 4‐OI (25 mg/kg) or vehicle once daily for 4 weeks. The salivary flow rate was calculated to assess gland secretion function. Hematoxylin and eosin staining was used to analyze morphological alterations. Masson staining was used to quantify collagen deposition. Oil Red O staining was used to evaluate lipid droplet accumulation. Western blotting was used to detect protein expression levels. Metabolomics, transcriptome, and molecular docking analyses were performed to identify potential mechanisms of action. Functional assays revealed that 4‐OI increased the salivary flow rate. AMPKα has been identified as a direct target of 4‐OI by molecular docking. 4‐OI upregulates AMPKα phosphorylation, decreases lipid droplet deposition, and relieves fibrosis to restore the aging characteristics of the gland. 4‐OI regulates fatty acid oxidation (FAO) in the parotid gland through AMPKα/PPARα signaling pathways. The protective effects of 4‐OI in aged mice were abolished by Compound C and GW6471, which inhibit AMPKα and PPARα, respectively. In addition, we found that 4‐OI treatment ameliorated parotid gland aging‐induced oxidative reactions, enhanced mitochondrial biogenesis, and activated the Nrf2 pathway. Moreover, the Nrf2 inhibitor ML385 was used to validate this mechanism. Treatment with 4‐OI improved the aging of the parotid gland by increasing gland FAO, decreasing gland fibrosis, and preventing oxidative reactions. This was achieved by upregulating the AMPKα/Nrf2 and AMPKα/PPARα signaling pathways.
Mechanistic studies revealed that XAN attenuates inflammation by regulating the SIRT1/HIF‐1α/glycolysis signaling axis in macrophages, indicating that its anti‐inflammatory activity involves modulation of cellular energy metabolism.
Yu-Yan Zhou, Yu-Yun Zhou, Ruo-Xuan Xiang et al.· Pharmacology Research & Pers...· 0 citations
Tgy‐N protects against D‐gal‐induced hepatic senescence through oxidative stress mitigation and NF‐κB pathway inhibition, supporting its potential as a natural functional food for liver health.
Wei-Hong Chen, Ming-Mei Li, Ling-Xiao Ye et al.· Food Science & Nutrition· 0 citations
PDG ameliorates DOP by dual targeting p65 and GSK3β, coordinately inhibiting NF-κB-mediated inflammation and activating the β-catenin osteogenic program, highlighting its therapeutic potential for DOP.
Wen-Qi Jin, Yu-Jing Tan, Lei Zhang et al.· Phytotherapy Research· 0 citations
Findings indicate that ferroptosis and oxidative stress are pivotal in SIDD, and AC was demonstrated to potentially alleviate SIDD by regulating the PI3K/AKT/NRF2 pathway.
Background Sepsis‐induced acute lung injury (SI‐ALI) represents a life‐threatening condition driven by dysregulated immune responses and redox imbalance. Demethoxycurcumin (DMC), a bioactive analog of curcumin, exhibits marked anti‐inflammatory and free radical‐scavenging capacities. Despite its potential, the precise...
Jing Tang, Q. Zhao, Ju Liu et al.· Mediators of Inflammation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.